CA
NZ
UK
AU
IND
US
Allegiant Travel Company (NASDAQ:ALGT) has unveiled a major expansion of its national route network, announcing 30 new nonstop routes across 35 cities in the United States. This development includes the airline’s entry into four new markets: La Crosse in Wisconsin, Trenton in New Jersey, …
Zymeworks Inc. (Nasdaq:ZYME) has launched a strategic initiative designed to maximize long-term value from its growing roster of licensed biotherapeutics and healthcare assets. This decision follows encouraging developments across key programs, including positive topline data from the pivotal Phase 3 HERIZON-GEA-01 trial for Ziihera …
AerCap Holdings N.V., (NYSE:AER), one of the world’s leading aviation leasing companies, has entered into a new agreement with FlySafair for the lease of five Boeing aircraft—three new Boeing 737 MAX 8 jets and two Boeing 737-800NG aircraft. Announced at the Dubai Airshow 2025, …
Axalta (NYSE:AXTA) and AkzoNobel have entered into a definitive agreement to merge in an all-stock transaction, forming a coatings powerhouse with anenterprise valueof approximately USD 25 billion. Themergedcompany will bring together two long-respected players with complementary strengths across decorative paints, industrial coatings, mobility applications, …
Southeast Asia’s smartphone market saw a marginal 1% year-on-year decline in 3Q25, with shipments totaling 25.6 million units, according to Omdia’s(NASDAQ:TTGT)latest findings. This marks the third consecutive quarter of contraction, underscoring continued consumer caution and intense competition in a region where more than 60% …
Market Movers:On Tuesday, the top gainers were Olema Pharmaceuticals, Inc. (+136.38%), followed by Epsium Enterprise Limited (+91.55%). On the contrary SMX (Security Matters) Public Limited Company (-37.14%), and HCW Biologics Inc. (-21.24%) declined the most the same day.
Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) has achieved a major regulatory milestone as the U.S.Food and Drug Administration approvedREDEMPLO (plozasiran) for the treatment of adult patients with familial chylomicronemia syndrome. This marks the company’s first FDA-approved medicine and represents a pivotal step in its evolution from …
Global-e Online Ltd. (NASDAQ:GLBE) a leading direct-to-consumer cross-border e-commerce company, reported a profitable third quarter on Wednesday, marking a significant turnaround from the prior year’s loss. Net profit reached USD 13.18 million, compared to a USD 22.56 million loss during the same period last …
Stellantis (NYSE:STLA) has taken a major step toward improving the electric vehicle ownership experience by announcing the adoption of the North American Charging System for select battery-electric vehicles across North America, Japan, and South Korea. The decision positions Stellantis alongside a growing list of …
Genmab A/S (NASDAQ:GMAB) has received a major regulatory milestone with the U.S.Food and Drug Administrationgranting approval for EPKINLY (epcoritamab-bysp) in combination with rituximab and lenalidomide, collectively known as EPKINLY + R2, for adults with relapsed or refractory follicular lymphoma. This approval introduces the first-ever …
Please wait processing your request...